Haploinsufficiency of eNOS mitigates beneficial effects of maternal exercise on fetal heart development during pregestational diabetes
Ryleigh van Neck, Xiangru Lu, Lambertus J. WisseiD, Marco C. DeRuiteriD, Qingping FengiD
Abstract
BackgroundPregestational diabetes (PGD) increases congenital heart defect (CHD) risk over five-fold. Maternal exercise enhances endothelial nitric oxide synthase (eNOS) activity, benefiting embryos, though its causal role remains unclear. This study investigated eNOSs role in maternal exercise-mediated protection of fetal heart development in a PGD mouse model. MethodsPGD was induced in eNOS+/- or wild-type (WT) female mice via streptozotocin before breeding with WT or eNOS+/- males. Pregnant females had access to a running wheel for voluntary exercise or remained sedentary. Fetuses were collected at embryonic day (E) 18.5 for genotyping and CHD assessment. E12.5 hearts were analyzed for proliferation, apoptosis, oxidative stress, and eNOS protein levels. ResultsMaternal exercise normalized litter size and mortality rates in offspring of diabetic eNOS+/- females but did not reduce CHD incidence in offspring of WT or eNOS+/- females with PGD. CHDs included septal defects, double outlet right ventricle, and valve defects. Exercise increased coronary artery density but not capillary density. Proliferation deficits at E12.5 were restored by exercise, yet oxidative stress remained elevated. Maternal exercise in eNOS+/- dams during PGD did not significantly change eNOS protein levels in both eNOS+/+ and eNOS+/- fetal hearts. Offspring genotype did not impact CHD incidence, cell proliferation, apoptosis or oxidative stress. ConclusionsMaternal exercise does not prevent CHDs in PGD offspring of eNOS+/- mice. Its ability to mitigate PGD-induced oxidative stress is eNOS-dependent and essential for improving heart morphology. Graphic Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=178 SRC="FIGDIR/small/647329v1_ufig1.gif" ALT="Figure 1"> View larger version (42K): org.highwire.dtl.DTLVardef@4c9e4forg.highwire.dtl.DTLVardef@2d60fforg.highwire.dtl.DTLVardef@13b2d72org.highwire.dtl.DTLVardef@249a0c_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Sapropterin Treatment Prevents Congenital Heart Defects Induced by Pregestational Diabetes in Mice
A. Engineer, T. Saiyin, … Q. Feng·bioRxiv·Jul 23, 2018
- ER stress and lipid imbalance drive embryonic cardiomyopathy in a human heart organoid model of pregestational diabetes
A. Kostina, Y. Lewis-Israeli, … A. Aguirre·bioRxiv·Jun 7, 2023
- Single-cell Transcriptomic Profiling Unveils Cardiac Cell-type Specific Response to Maternal Hyperglycemia Underlying the Risk of Congenital Heart Defects
Sathiyanarayanan Manivannan, Corrin Mansfield, … Madhumita Basu·bioRxiv·May 28, 2021
- Single-Cell Multimodal Profiling Reveals Maternal Diabetes-Nkx2-5 Interaction in Congenital Heart Disease in a Genetic Model Recapitulating Human Embryopathies
Stéphanie Ibrahim, Julien Maurizio, … Sonia Stefanovic·bioRxiv·Oct 13, 2026
- Maternal obesity causes fetal cardiac hypertrophy and alters adult offspring myocardial metabolism in mice
O. R. Vaughan, F. Rosario, … T. Jansson·The Journal of PhysiologyPeer-reviewed·May 11, 2022
- Extracellular matrix and cyclic stretch alter fetal cardiomyocyte proliferation and maturation in a rodent model of heart hypoplasia
M. C. Watson, C. Williams, … L. D. Black·bioRxiv·Aug 17, 2020